If you made any changes in Pure these will be visible here soon.

Research Output 2003 2019

Filter
Article
2019

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

Dieci, M. V., Conte, P., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Piacentini, F., Maiorana, A., Orvieto, E., Sanders, M., Miglietta, F., Balduzzi, S. & 2 others, D'Amico, R. & Guarneri, V., Mar 1 2019, In : Annals of Oncology. 30, 3, p. 418-423 6 p.

Research output: Contribution to journalArticle

Open Access
Tumor-Infiltrating Lymphocytes
Disease-Free Survival
Breast Neoplasms
Confidence Intervals
Proportional Hazards Models

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

Dieci, M. V., Conte, P., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Piacentini, F., Maiorana, A., Orvieto, E., Sanders, M., Miglietta, F., Balduzzi, S. & 2 others, D'Amico, R. & Guarneri, V., 2019, In : Annals of Oncology. 30, 3, p. 418-423 6 p.

Research output: Contribution to journalArticle

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

Dieci, M. V., Conte, P., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Piacentini, F., Maiorana, A., Orvieto, E., Sanders, M., Miglietta, F., Balduzzi, S. & 2 others, D'Amico, R. & Guarneri, V., Mar 1 2019, In : Annals of Oncology. 30, 3, p. 418-423 6 p.

Research output: Contribution to journalArticle

Tumor-Infiltrating Lymphocytes
Disease-Free Survival
Breast Neoplasms
Hematoxylin
Eosine Yellowish-(YS)

Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer?

Palleschi, M., Maltoni, R., Sarti, S., Melegari, E., Bravaccini, S. & Rocca, A., Jan 1 2019, (Accepted/In press) In : Breast Journal.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Immunotherapy
Therapeutics
Patient Selection
Disease-Free Survival

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

Dieci, M. V., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Musolino, A., Garrone, O., Donadio, M., Rimanti, A., Beano, A., Zamagni, C., Soto Parra, H., Piacentini, F., Danese, S., Ferro, A., Cagossi, K., Sarti, S. & 12 others, Gambaro, A. R., Romito, S., Bazan, V., Amaducci, L., Moretti, G., Foschini, M. P., Balduzzi, S., Vicini, R., D'Amico, R., Griguolo, G., Guarneri, V. & Conte, P. F., Nov 21 2019, In : BMC Medicine. 17, 1, 207.

Research output: Contribution to journalArticle

Breast Neoplasms
Disease-Free Survival
Neoplasms
Neoplasm Staging
Biological Factors

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

Dieci, M. V., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Musolino, A., Garrone, O., Donadio, M., Rimanti, A., Beano, A., Zamagni, C., Soto Parra, H., Piacentini, F., Danese, S., Ferro, A., Cagossi, K., Sarti, S. & 12 others, Gambaro, A. R., Romito, S., Bazan, V., Amaducci, L., Moretti, G., Foschini, M. P., Balduzzi, S., Vicini, R., D'Amico, R., Griguolo, G., Guarneri, V. & Conte, P. F., 2019, In : BMC Medicine. 17, 1

Research output: Contribution to journalArticle

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

Dieci, M. V., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Musolino, A., Garrone, O., Donadio, M., Rimanti, A., Beano, A., Zamagni, C., Soto Parra, H., Piacentini, F., Danese, S., Ferro, A., Cagossi, K., Sarti, S. & 12 others, Gambaro, A. R., Romito, S., Bazan, V., Amaducci, L., Moretti, G., Foschini, M. P., Balduzzi, S., Vicini, R., D'Amico, R., Griguolo, G., Guarneri, V. & Conte, P. F., Nov 21 2019, In : BMC Medicine. 17, 1, p. 1-9 9 p., 207.

Research output: Contribution to journalArticle

Breast Neoplasms
Disease-Free Survival
Neoplasms
Neoplasm Staging
Biological Factors

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.

Dieci, M. V., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Musolino, A., Garrone, O., Donadio, M., Rimanti, A., Beano, A., Zamagni, C., Soto Parra, H., Piacentini, F., Danese, S., Ferro, A., Cagossi, K., Sarti, S. & 12 others, Gambaro, A. R., Romito, S., Bazan, V., Amaducci, L., Moretti, G., Foschini, M. P., Balduzzi, S., Vicini, R., D'Amico, R., Griguolo, G., Guarneri, V. & Conte, P. F., Nov 21 2019, In : BMC Medicine. 17, 1, 207.

Research output: Contribution to journalArticle

Breast Neoplasms
Disease-Free Survival
Neoplasms
Neoplasm Staging
Biological Factors
2018

Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?

Bronte, G., Bravaccini, S., Ravaioli, S., Puccetti, M., Scarpi, E., Andreis, D., Tumedei, M. M., Sarti, S., Cecconetto, L., Pietri, E., De Simone, V., Maltoni, R., Bonafè, M., Amadori, D. & Rocca, A., Aug 1 2018, In : Translational Oncology. 11, 4, p. 950-956 7 p.

Research output: Contribution to journalArticle

Androgen Receptors
Breast Neoplasms
Neoplasm Metastasis
Neoplasms
Tumor Biomarkers

Androgen receptor in advanced breast cancer: Is it useful to predict the efficacy of anti-estrogen therapy?

Bronte, G., Rocca, A., Ravaioli, S., Puccetti, M., Tumedei, M. M., Scarpi, E., Andreis, D., Maltoni, R., Sarti, S., Cecconetto, L., Fedeli, A., Pietri, E., De Simone, V., Asioli, S., Bravaccini, S. & Amadori, D., Mar 27 2018, In : BMC Cancer. 18, 1, 348.

Research output: Contribution to journalArticle

Androgen Receptors
Estrogens
Breast Neoplasms
Progesterone Receptors
Estrogen Receptors
Metformin
Disease-Free Survival
Clinical Trials
Breast Neoplasms
Drug Therapy
Metformin
Disease-Free Survival
Clinical Trials
Breast Neoplasms
Drug Therapy

Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial

Nanni, O., Amadori, D., De Censi, A., Rocca, A., Freschi, A., Bologna, A., Gianni, L., Rosetti, F., Amaducci, L., Cavanna, L., Foca, F., Sarti, S., Serra, P., Valmorri, L., Bruzzi, P., Corradengo, D., Gennari, A., Scaltriti, L., Turolla, G. M., Dazzi, C. & 6 others, Cortesi, L., Giovanis, P., Saracchini, S., Ciccarese, M., Carrozza, F. & investigators, MYME., 2018, In : Breast Cancer Research and Treatment.

Research output: Contribution to journalArticle

2017

Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer

Rocca, A., Cecconetto, L., Passardi, A., Melegari, E., Andreis, D., Monti, M., Maltoni, R., Sarti, S., Pietri, E., Schirone, A., Fabbri, F., Donati, C., Nanni, O., Fedeli, A., Faedi, M. & Amadori, D., May 1 2017, In : Cancer Chemotherapy and Pharmacology. 79, 5, p. 863-871 9 p.

Research output: Contribution to journalArticle

Toxicity
Breast Neoplasms
Diarrhea
Hand-Foot Syndrome
Anthracyclines
2016

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer

Musolino, A., Naldi, N., Dieci, M. V., Zanoni, D., Rimanti, A., Boggiani, D., Sgargi, P., Generali, D., Piacentini, F., Ambroggi, M., Cagossi, K., Gianni, L., Sarti, S., Bisagni, G., Ardizzoni, A., Conte, P. & Guarneri, V., Jul 5 2016, (Accepted/In press) In : Pharmacogenomics Journal.

Research output: Contribution to journalArticle

Immunoglobulin Fragments
Immunoglobulin G
Breast Neoplasms
Antibody-Dependent Cell Cytotoxicity
Drug Therapy

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer

Musolino, A., Naldi, N., Dieci, M. V., Zanoni, D., Rimanti, A., Boggiani, D., Sgargi, P., Generali, D. G., Piacentini, F., Ambroggi, M., Cagossi, K., Gianni, L., Sarti, S., Bisagni, G., Ardizzoni, A., Conte, P. F. & Guarneri, V., Jul 5 2016, (Accepted/In press) In : Pharmacogenomics Journal.

Research output: Contribution to journalArticle

Immunoglobulin Fragments
Immunoglobulin G
Breast Neoplasms
Antibody-Dependent Cell Cytotoxicity
Drug Therapy

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer

Musolino, A., Naldi, N., Dieci, M. V., Zanoni, D., Rimanti, A., Boggiani, D., Sgargi, P., Generali, D., Piacentini, F., Ambroggi, M., Cagossi, K., Gianni, L., Sarti, S., Bisagni, G., Ardizzoni, A., Conte, P. & Guarneri, V., Oct 2016, In : Pharmacogenomics Journal. 16, 5, p. 472-7 6 p.

Research output: Contribution to journalArticle

Immunoglobulin Fragments
Immunoglobulin G
Breast Neoplasms
Antibody-Dependent Cell Cytotoxicity
Drug Therapy

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer

Musolino, A., Naldi, N., Dieci, M. V., Zanoni, D., Rimanti, A., Boggiani, D., Sgargi, P., Generali, D., Piacentini, F., Ambroggi, M., Cagossi, K., Gianni, L., Sarti, S., Bisagni, G., Ardizzoni, A., Conte, P. & Guarneri, V., Jul 5 2016, (Accepted/In press) In : Pharmacogenomics Journal.

Research output: Contribution to journalArticle

Immunoglobulin Fragments
Immunoglobulin G
Breast Neoplasms
Antibody-Dependent Cell Cytotoxicity
Drug Therapy
2015

Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer

Rocca, A., Farolfi, A., Maltoni, R., Carretta, E., Melegari, E., Ferrario, C., Cecconetto, L., Sarti, S., Schirone, A., Fedeli, A., Andreis, D., Pietri, E., Ibrahim, T., Montalto, E. & Amadori, D., May 27 2015, In : Breast Cancer Research and Treatment. 152, 1, p. 57-65 9 p.

Research output: Contribution to journalArticle

Progesterone Receptors
Breast Neoplasms
Neoplasm Metastasis
Therapeutics
Neoplasms

Identification of BRAF 3'UTR isoforms in melanoma

Marranci, A., Tuccoli, A., Vitiello, M., Mercoledi, E., Sarti, S., Lubrano, S., Evangelista, M., Fogli, A., Valdes, C., Russo, F., Dal Monte, M., Caligo, M. A., Pellegrini, M., Capobianco, E., Tsinoremas, N. & Poliseno, L., Jan 1 2015, In : Journal of Investigative Dermatology. 135, 6, p. 1694-1697 4 p.

Research output: Contribution to journalArticle

Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy

Rocca, A., Andreis, D., Fedeli, A., Maltoni, R., Sarti, S., Cecconetto, L., Pietri, E., Schirone, A., Bravaccini, S., Serra, P., Farolfi, A. & Amadori, D., Oct 3 2015, In : Expert Opinion on Drug Metabolism and Toxicology. 11, 10, p. 1647-1663 17 p.

Research output: Contribution to journalArticle

Pharmacodynamics
Pharmacokinetics
Breast Neoplasms
docetaxel
Therapeutics

Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer

Guarneri, V., Dieci, M. V., Frassoldati, A., Maiorana, A., Ficarra, G., Bettelli, S., Tagliafico, E., Bicciato, S., Generali, D. G., Cagossi, K., Bisagni, G., Sarti, S., Musolino, A., Ellis, C., Crescenzo, R. & Conte, P., Aug 5 2015, In : The oncologist. 20, 9, p. 1001-1010 10 p.

Research output: Contribution to journalArticle

Neoadjuvant Therapy
Epidermal Growth Factor
Biomarkers
Breast Neoplasms
Drug Therapy
2014

Long-term complete response in a patient with liver metastases from breast cancer treated with metronomic chemotherapy

Cecconetto, L., Gardini, A. C., Tenti, E., Maltoni, R., Bravaccini, S., Oboldi, D., Zoli, W., Serra, P., Donati, C., Sarti, S., Amadori, D. & Rocca, A., 2014, In : Tumori. 100, 3

Research output: Contribution to journalArticle

Breast Neoplasms
Neoplasm Metastasis
Drug Therapy
Liver
Vascular Endothelial Growth Factor Receptor-2
2013

The role of liposomal anthracyclines in metastatic breast cancer

Gennari, A., Piccininno, M. & Sarti, S., Mar 2013, In : Current Breast Cancer Reports. 5, 1, p. 23-30 8 p.

Research output: Contribution to journalArticle

Anthracyclines
Breast Neoplasms
Doxorubicin
Epirubicin
Safety

Trastuzumab-induced cardiotoxicity in early breast cancer patients: A retrospective study of possible risk and protective factors

Farolfi, A., Melegari, E., Aquilina, M., Scarpi, E., Ibrahim, T., Maltoni, R., Sarti, S., Cecconetto, L., Pietri, E., Ferrario, C., Fedeli, A., Faedi, M., Nanni, O., Frassineti, G. L., Amadori, D. & Rocca, A., May 2013, In : Heart. 99, 9, p. 634-639 6 p.

Research output: Contribution to journalArticle

Retrospective Studies
Breast Neoplasms
Epirubicin
Medical Oncology
Trastuzumab
2012

Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: Results of the randomized phase II CHER-LOB study

Guarneri, V., Frassoldati, A., Bottini, A., Cagossi, K., Bisagni, G., Sarti, S., Ravaioli, A., Cavanna, L., Giardina, G., Musolino, A., Untch, M., Orlando, L., Artioli, F., Boni, C., Generali, D. G., Serra, P., Bagnalasta, M., Marini, L., Piacentini, F., D'Amico, R. & 1 others, Conte, P., Jun 1 2012, In : Journal of Clinical Oncology. 30, 16, p. 1989-1995 7 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Drug Therapy
Epirubicin
Segmental Mastectomy
Anthracyclines
2010

A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer

Rocca, A., Maltoni, R., Passardi, A., Massa, I., Aquilina, M., Ridolfi, R., Ibrahim, T., Cecconetto, L., Sarti, S., Pietri, E., Nanni, O. & Amadori, D., Apr 2010, In : Cancer Chemotherapy and Pharmacology. 65, 5, p. 871-876 6 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Anthracyclines
Maximum Tolerated Dose
Epirubicin
Febrile Neutropenia
2009

Misclassification of breast cancer as cause of death in a service screening area

Goldoni, C. A., Bonora, K., Ciatto, S., Giovannetti, L., Patriarca, S., Sapino, A., Sarti, S., Puliti, D. & Paci, E., Jul 2009, In : Cancer Causes and Control. 20, 5, p. 533-538 6 p.

Research output: Contribution to journalArticle

Cause of Death
Death Certificates
Breast Neoplasms
Process Assessment (Health Care)
Mortality
2007

The impact of chemotherapy-induced nausea and vomiting on health-related quality of life

Ballatori, E., Roila, F., Ruggeri, B., Betti, M., Sarti, S., Soru, G., Cruciani, G., Di Maio, M., Andrea, B. & Deuson, R. R., Feb 2007, In : Supportive Care in Cancer. 15, 2, p. 179-185 7 p.

Research output: Contribution to journalArticle

Nausea
Vomiting
Quality of Life
Drug Therapy
Emetics
2005

Molecular staging of the sentinel lymph node in melanoma patients: Correlation with clinical outcome

Romanini, A., Manca, G., Pellegrino, D., Murr, R., Sarti, S., Bianchi, F., AlSharif, A., Orlandini, C., Zucchi, V., Castagna, M., Gandini, D., Salimbeni, G., Ghiara, F., Barachini, P. & Mariani, G., Nov 2005, In : Annals of Oncology. 16, 11, p. 1832-1840 9 p.

Research output: Contribution to journalArticle

Melanoma
Reverse Transcriptase Polymerase Chain Reaction
Polymerase Chain Reaction
Monophenol Monooxygenase
MART-1 Antigen
2003

Brain metastases from malignant melanoma

Chiarion-Sileni, V., Murr, R., Pigozzo, J., Sarti, S., Tomassi, O. & Romanini, A., 2003, In : FORUM - Trends in Experimental and Clinical Medicine. 13, 2, p. 170-185 16 p.

Research output: Contribution to journalArticle

Melanoma
Central Nervous System
Neoplasm Metastasis
Brain
Radiosurgery

Brain metastases from malignant melanoma.

Chiarion-Sileni, V., Murr, R., Pigozzo, J., Sarti, S., Tomassi, O. & Romanini, A., 2003, In : FORUM - Trends in Experimental and Clinical Medicine. 13, 2

Research output: Contribution to journalArticle

Melanoma
Central Nervous System
Neoplasm Metastasis
Brain
Radiosurgery